spacer
home > events calendar > more about event
PHARMACEUTICAL INDUSTRY EVENTS CALENDAR

14th Annual Biomarkers Congress

Biomarkers Congress UK 2019

21-22 February 2019
Manchester Central Convention Complex, UK

Oxford Global is proud to present for the 14th year our flagship Biomarkers Congress, taking place 21 22 February 2019 in Manchester, UK. An updated programme ensures you will benefit from talks on the latest strategies and technologies impacting growth in the biomarker industry.

Biomarkers are a fundamental part of drug development, playing a critical role in drug discovery, preclinical and clinical development, diagnostics and prognostics. Across two days and over 55 presentations, senior experts will provide a comprehensive look at the marketplace to make sure you leave with an increased knowledge of the current trends influencing biomarker research. 

2019 sees the return of our popular discovery, precision medicine and clinical streams designed to provide updates across multiple therapeutic areas, from market-dominating oncology and neuroscience through to more emerging fields such as infectious, cardiovascular and rare diseases. Benefit further from case studies on topical technology innovation in this space: imaging techniques, proteomics and immuno-assays. We are also pleased to announce an additional two streams highlighting important opportunities in the biomarker market: Biomarkers for Early Detection and Prognosis and Digital Biomarkers.

Key Speakers include:

Mark Fidock, Vice President, AstraZeneca 

Frank Kramer, Director Biomarker Strategist, Bayer 

Thomas Hach, Director Healthcare Systems, Novartis 

Devangi Mehta, Director, Development Biomarkers and Bioanalytical Sciences, Biogen 

Kay-Gunnar Stubenrauch, Head of Large Molecule Bioanalytical Sciences 1, Roche 

Joanne Hackett, Chief Commercial Officer, Genomics England

The two day congress offers an interactive platform for high level scientific and business discussions, ensuring valuable networking and interactive sessions from panels and roundtables through to two workshops on clinical biomarker assay validation and data analytics.  It brings together over 350 senior industry experts and key opinion leaders in biomarkers. For more information about the programme and registration, please contact Angela Fernandez Saez at a.fernandez@oxfordglobal.co.uk

Contact Details: 

General Enquiries: +44 (0) 1865 248455

For speaker opportunities contact j.thomson@oxfordglobal.co.uk
For sponsorship opportunities contact sponsorship@oxfordglobal.co.uk
For information on registration contact marketing@oxfordglobal.co.uk
For press & marketing enquiries contact a.saez@oxfordglobal.co.uk

phone +44 1865 248 455
email marketing@oxfordglobal.co.uk
web https://bit.ly/2zInOAb
email Manchester, UK
 
Print this page
Send to a friend
   
spacer
Industry Events

CPhI Korea

21-23 August 2019, COEX, Seoul, South Korea

CPhI Korea provides a dynamic meeting place for a wide range of industry suppliers to engage with purchasers and decision makers from the pharmaceutical industry in Korea and the surrounding region. The exhibition showcases the whole pharma supply chain from ingredients, contracting services to machinery and biopharmaceuticals. It also hosts an extensive conference programme covering the latest trends and topics within the regional market.
More info >>

White Papers

Overcoming research challenges with Adaptive Trials

PCI Pharma Services

There has been cause for concern within the pharmaceutical industry over the last five years, regarding increasing research and development costs, combined with a fall in the number of new drugs brought to market. In an attempt to overcome this issue there has been a significant rise in the use of adaptive clinical trial designs, whilst saving time and money as well as facilitating more effective decision making. One of the biggest challenges that pharmaceutical companies have experienced has been delivering compliant clinical trials supplies across diverse patient populations in the relatively short timeframes that adaptive trial designs require, remaining focused on ensuring that patient compliance and product quality is in no way compromised. This demand has led to the launch of fast response services that support Research and Development in responding to changing dosing regimens mid-trial.
More info >>


News and Press Releases

CPhI China opens with analysis pointing to a surge in growth in 2019

Shanghai, 23rd May 2019: New analysis released ahead of CPhI & P-MEC China (#CPhIChina and #PMECChina) co-organized by Informa Markets, CCCMHPIE, and Shanghai Sinoexpo Informa Markets forecasts that China will continue to grow strongly through 2019/20, thanks in part to a marked improvement in its global reputation.
More info >>

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement